Search Results - "MORTON, L. D"

Refine Results
  1. 1
  2. 2

    Functional RET G691S polymorphism in cutaneous malignant melanoma by Narita, N, Tanemura, A, Murali, R, Scolyer, R A, Huang, S, Arigami, T, Yanagita, S, Chong, K K, Thompson, J F, Morton, D L, Hoon, D S

    Published in Oncogene (27-08-2009)
    “…RET proto-oncogene encodes a receptor tyrosine kinase whose ligand is glial cell line-derived neurotrophic factor (GDNF), and its polymorphism at G691S…”
    Get full text
    Journal Article
  3. 3

    The use of topiramate in refractory status epilepticus by TOWNE, A. R, GARNETT, L. K, WATERHOUSE, E. J, MORTON, L. D, DELORENZO, R. J

    Published in Neurology (28-01-2003)
    “…In cases of refractory status epilepticus (RSE) unresponsive to sequential trials of multiple agents, a suspension of topiramate administered via nasogastric…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Prognostic factors in 1,521 melanoma patients with distant metastases by BARTH, A, WANEK, L. A, MORTON, D. L

    “…Although over 7,000 people die from malignant melanoma each year, there are limited prognostic data for patients with metastatic disease. A retrospective…”
    Get full text
    Journal Article
  6. 6

    Autoregulation of cerebral blood flow in fetuses with congenital heart disease: the brain sparing effect by Donofrio, M T, Bremer, Y A, Schieken, R M, Gennings, C, Morton, L D, Eidem, B W, Cetta, F, Falkensammer, C B, Huhta, J C, Kleinman, C S

    Published in Pediatric cardiology (01-09-2003)
    “…Fetuses with congenital heart disease (CHD) have circulatory abnormalities that may compromise cerebral oxygen delivery. We believe that some CHD fetuses with…”
    Get full text
    Journal Article
  7. 7

    Correlation of specific immune responses with survival in melanoma patients with distant metastases receiving polyvalent melanoma cell vaccine by Hsueh, E C, Gupta, R K, Qi, K, Morton, D L

    Published in Journal of clinical oncology (01-09-1998)
    “…The mechanisms that underlie the clinical efficacy of melanoma vaccines are not well understood. We hypothesized that the type and strength of the immune…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Improved axillary staging of breast cancer with sentinel lymphadenectomy by GIULIANO, A. E, DALE, P. S, TURNER, R. R, MORTON, D. L, EVANS, S. W, KRASNE, D. L

    Published in Annals of surgery (01-09-1995)
    “…The authors evaluated the effect of intraoperative lymphatic mapping and sentinel lymphadenectomy (SLND) on the axillary staging of patients with carcinoma of…”
    Get full text
    Conference Proceeding Journal Article
  10. 10

    Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay by Hoon, D S, Wang, Y, Dale, P S, Conrad, A J, Schmid, P, Garrison, D, Kuo, C, Foshag, L J, Nizze, A J, Morton, D L

    Published in Journal of clinical oncology (01-08-1995)
    “…The objective of the study was to develop a sensitive multimarker polymerase chain reaction (PCR) assay to detect circulating melanoma cells in patient blood…”
    Get more information
    Journal Article
  11. 11

    Prognostic Significance of Occult Metastases Detected by Sentinel Lymphadenectomy and Reverse Transcriptase–Polymerase Chain Reaction in Early-Stage Melanoma Patients by BOSTICK, P. J, MORTON, D. L, TURNER, R. R, HUYNH, K. T, WANG, H.-J, ELASHOFF, R, ESSNER, R, HOON, D. S. B

    Published in Journal of clinical oncology (01-10-1999)
    “…Detection of micrometastases in the regional tumor-draining lymph nodes is critical for accurate staging and prognosis in melanoma patients. We hypothesized…”
    Get full text
    Journal Article
  12. 12

    Molecular Staging of Early Colon Cancer on the Basis of Sentinel Node Analysis: A Multicenter Phase II Trial by BILCHIK, Anton J, SAHA, Sukamal, WIESE, David, STONECYPHER, James A, WOOD, Thomas F, SOSTRIN, Stuart, TURNER, Roderick R, WANG, He-Jing, MORTON, Donald L, HOON, Dave S. B

    Published in Journal of clinical oncology (15-02-2001)
    “…Approximately 30% of patients with American Joint Committee on Cancer stage I or II colorectal cancer (CRC) develop systemic disease. We hypothesized that…”
    Get full text
    Journal Article
  13. 13

    Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck by Morton, D L, Wen, D R, Foshag, L J, Essner, R, Cochran, A

    Published in Journal of clinical oncology (01-09-1993)
    “…We developed intraoperative lymphatic mapping with selective lymphadenectomy (SLND) to identify micrometastatic spread of cutaneous melanoma to regional lymph…”
    Get more information
    Journal Article
  14. 14

    Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence by HOON, D. S. B, BOSTICK, P, KUO, C, OKAMOTO, T, WANG, H.-J, ELASHOFF, R, MORTON, D. L

    Published in Cancer research (Chicago, Ill.) (15-04-2000)
    “…Improvement is needed in the ability to evaluate the prognosis of melanoma patients who are clinically disease-free but likely to develop recurrent metastatic…”
    Get full text
    Journal Article
  15. 15

    Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas by Chi, DD, Merchant, RE, Rand, R, Conrad, AJ, Garrison, D, Turner, R, Morton, DL, Hoon, DS

    Published in The American journal of pathology (01-06-1997)
    “…Both melanocytes and glial cells are derived embryologically from the neural ectoderm. Their malignant transformed counterparts, melanoma and glioma cells,…”
    Get full text
    Journal Article
  16. 16

    Cytoreductive surgery and adjuvant immunotherapy: a new management paradigm for metastatic melanoma by Morton, D. L, Ollila, D. W, Hsueh, E. C, Essner, R, Gupta, R. K

    Published in CA: a cancer journal for clinicians (01-03-1999)
    “…Although patients with metastatic disease are usually not offered surgery as part of their comprehensive treatment plan, the authors suggest that surgical…”
    Get full text
    Journal Article
  17. 17

    Immune response to postsurgical adjuvant active immunotherapy with Canvaxin polyvalent cancer vaccine: correlations with clinical course of patients with metastatic melanoma by Morton, D L

    Published in Developments in biologicals (2004)
    “…The efficacy of cytoreductive surgery for metastatic melanoma depends in part on the patient's immune response, which can be modulated by post-operative active…”
    Get more information
    Journal Article
  18. 18

    Ultrastaging of early colon cancer using lymphatic mapping and molecular analysis by Bilchik, A.J, Nora, D, Tollenaar, R.A.E.M, van de Velde, C.J.H, Wood, T, Turner, R, Morton, D.L, Hoon, D.S.B

    Published in European journal of cancer (1990) (01-05-2002)
    “…Approximately one-third of node-negative colon cancers will recur, possibly due to understaging and inadequate pathological examination of lymph nodes (LNs)…”
    Get full text
    Journal Article
  19. 19

    Lymphatic mapping improves staging during laparoscopic colectomy for cancer by WOOD, T. F, SPIRT, M, RANGEL, D, SHEN, P, TSIOULIAS, G. J, MORTON, D. L, BILCHIK, A. J

    Published in Surgical endoscopy (01-07-2001)
    “…Recently, lymphatic mapping (LM) of the sentinel lymph node (SN) has been coupled with ultrastaging methods to diagnose nodal micrometastases from colorectal…”
    Get full text
    Journal Article
  20. 20

    Kinetics of Three Lymphoscintigraphic Agents in Patients with Cutaneous Melanoma by Glass, Edwin C, Essner, Richard, Morton, Donald L

    Published in The Journal of nuclear medicine (1978) (01-07-1998)
    “…Although lymphoscintigraphy is commonly used for the preoperative evaluation of patients with cutaneous melanoma and for intraoperative identification of…”
    Get full text
    Journal Article